NEW! Investment Companies Centre

Skyepharma (SKP)

Sector:

Pharmaceuticals & Biotechnology

Index:

FTSE Fledgling

Market Cap

£33.58m

Change Today

Price Up4.00p ()

Share Price

151.50p

Holding(s) in Company

RNS Number : 9082E
Skyepharma PLC
02 October 2008
 




For filings with the FSA include the annex

For filings with issuer exclude the annex 


TR-1: Notifications of Major Interests in Shares


1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:


 

SKYEPHARMA PLC



2. Reason for notification (yes/no)


An acquisition or disposal of voting rights


X


An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 



An event changing the breakdown of voting rights



Other (please specify):______________



3. Full name of person(s) subject to notification obligation:


ORBIMED ADVISORS LLC


4. Full name of shareholder(s) (if different from 3):


 

CADUCEUS CAPITAL MASTER FUND LIMITED

 

CADUCEUS CAPITAL II, L.P.

 

UBS EUCALYPTUS FUND L.L.C

 

PW EUCALYPTUS FUND, LTD.

 

SUMMER STREET LIFE SCIENCES HEDGE FUND INVESTORS LLC

 


5. Date of transaction (and date on which the threshold is crossed or reached if different):


 

SEPTEMBER 26 2008


6. Date on which issuer notified:


OCTOBER 1 2008


7. Threshold(s) that is/are crossed or reached:


 

12.4%



8: Notified Details

A: Voting rights attached to shares


Class/type of shares

If possible use ISIN code

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares

Number of voting rights

Percentage of voting rights


Direct


Indirect


Direct


Indirect



GB00B3BFNB64


 

406,000


 

406,000


 

2,747,242


 

2,747,242



 

12.4%





B: Financial Instruments


Resulting situation after the triggering transaction


Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights









Total (A+B)


Number of voting rights

Percentage of voting rights


2,747,242


12.4%




9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:


NOT APPLICABLE

 


Proxy Voting:


10. Name of proxy holder:


NOT APPLICABLE

11. Number of voting rights proxy holder will cease to hold:



12. Date on which proxy holder will cease to hold voting rights:




13. Additional information:


NOT APPLICABLE

14 Contact name:


ERIC BITTELMAN

15. Contact telephone number:


001 212 739 6400


For notes on how to complete form TR-1 please see the FSA website. 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLDLLBBVBBFFBF

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).